The company has underperformed the Nasdaq over the past year. However, analysts are cautiously optimistic about its future prospects. A key strategy involves leveraging refurbished Xi surgical systems to expand its market reach. This move targets cost-sensitive customers and aims to broaden access beyond traditional hospital settings into ambulatory surgical centers. This expansion into new markets could potentially drive future growth, despite recent stock performance lagging behind the broader market index.